Corrigendum to ‘‘An overview of the preclinical toxicity...

Corrigendum to ‘‘An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (Thelin®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension” [Regul. Toxicol. Pharmacol. 2012, 95–103]

Owen, Keith, Cross, David M., Derzi, Mazin, Horsley, Elizabeth, Stavros, Fiona L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
64
Language:
english
Journal:
Regulatory Toxicology and Pharmacology
DOI:
10.1016/j.yrtph.2012.07.012
Date:
December, 2012
File:
PDF, 120 KB
english, 2012
Conversion to is in progress
Conversion to is failed